Your session is about to expire
← Back to Search
YES-ERACE Curriculum for Reducing Youth Violence (YES-ERACE Trial)
YES-ERACE Trial Summary
This trial will test whether the YES-ERACE curriculum, which focuses on empowering youth to address racism and racial discrimination, can reduce violent behavior, including race-based victimization.
YES-ERACE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.YES-ERACE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a student in 6th, 7th, or 8th grade.
- Group 1: YES-ERACE
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it feasible for me to participate in this investigation?
"The study is recruiting 370 minors aged 10-15 and residing within Genesee County Intermediate School District who are enrolled in afterschool programs, between the 6th to 8th grade, and have given assent."
How many participants are included in the present clinical experiment?
"Correct. According to clinicaltrials.gov, the trial is still actively recruiting participants and has been so since June 1st 2021 when it was first posted. The listing was last updated on April 19th 2022 indicating that 370 patients need to be recruited from one location for this study."
Is the current research seeking out individuals aged 35 and over?
"This trial is open to people aged 10-15. There are also other clinical trials available for patients who do not meet this age criteria: there are 10 studies that include participants under 18 and 27 research projects reserved for those above 65 years of age."
Is it still feasible to join this experiment?
"Affirmative. Online information from clinicaltrials.gov shows that, following a June 2021 post and April 2022 update, this medical trial is actively recruiting for 370 participants at one site."
Share this study with friends
Copy Link
Messenger